Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms

Journal of Pharmaceutical and Biomedical Analysis

Volumn 30, Issue 4, 2002, Pages 1385-1392

  Shama, S A ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

Alizarine derivatives; Dosage forms; Ion pair complexes; Spectrophotometry

Indexed keywords

ALIZARIN; ALIZARIN RED S; ALIZARIN YELLOW G; ANTHRACENE DERIVATIVE; ORPHENADRINE CITRATE; PHENYLEPHRINE; QUINALIZARIN; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CHEMICAL REACTION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DRUG ABSORPTION; DRUG DETERMINATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; ORPHENADRINE; PHENYLEPHRINE; SPECTROMETRY, GAMMA;

EID: 0037038424     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00437-5     Document Type: Article

References (28)

1. Stewart C. "Remington's of pharmaceutical" Drugs. 47:1996;416.
2. El-Neemms E.M., El-Zawawy F.M., Hassan S.S.M. Mikrochim. Acta. 110:1993;79.
3. Grigoreva A.S., Vorotyntsev V.M., Konakhorich N.F., Nokhor N.A., Kirichek L.M. Kion. Farm. Zh. 31:1997;10.
4. Amin A.S., El-Kousy N.M., Dessouki H.A., Sultan M. Egypt. J. Pharm. Sci. 39:1998;463.
5. El-Din M.K.S., Abuirjeie M.A., Abdel-Hay M.H. Anal. Lett. 24:1991;2186.
6. Al-Kaysi H.N., Salem M.A. Anal. Lett. 20:1987;1451.
7. Goth A. Medical Pharmacology Principle and Concepts. 10th ed. 1981;The Mosby C.V. Company.
8. El-Sayed M.A., Obiakara A.C., Uzodinma S.U. J. Assoc. Off. Anal. Chem. 64:1981;960.
9. Koshy E.T., Mitchner H. J. Pharm. Sci. 52:1963;802.
10. Shoukrallah I. Drug Dev. Ind. Pharm. 16:1990;2135.
11. Mahgoub H. Drug Dev. Ind. Pharm. 16:1990;2135.
12. Amer M.M., Taha A.M., El-Shabouri S.R., Khashaba P. J. Assoc. Off. Anal. Chem. 65:1982;894.
13. Korang M.A., Wahbi A.M., Mandour S., El-Sayed M.A. Anal. Lett. 18:1985;21.
14. Ahmed A.K.S., El-Gendy A.E., Ellaithy M.M. Egypt J. Pharm. Sci. 2:1991;45.
15. Solich P., Polydorou C.K., Koupparis M.A., Efstathiou C.E. J. Pharm. Biomed. Anal. 22:2000;781.
16. Martin M.A., Delcastillo D., Prados P. Talanta. 40:1993;1719.
17. De Beer J.O., Vandenbroucke C.V., Massart D.L. J. Pharm. Biomed. Anal. 12:1994;1379.
18. Smelo M.J., Stromberg R. J. Assoc. Off. 47:1991;289.
19. Smelo M.J., Stromberg R. Anal. Abstr. 54:1991;28.
20. Ruchkin V.E., Tyuka Vkina N.A., Rulenko I.A., Akhtonova N.K., Kolesnik A., Litvinenko V.I. Farm. Zh. (Kiev). 6:1991;62.
21. Ruchkin V.E., Tyuka Vkina N.A., Rulenko I.A., Akhtonova N.K., Kolesnik A., Litvinenko V.I. Anal. Abstr. 55:(2):1993;G4.
22. Britton H.T.S. Hydrogen Ions. 4th ed. 1952;Chapman & Hall, London.
23. United States Pharmacopeia, 24th Rev. The National Formulary, 19th Rev. The United States Pharmacopeial Convention, Rockville, MD, 2000.
24. Job P. Ann. Chim. 8:1928;113.
25. Amine A.S., Shama S.A. Bull. Fac. Sci. Assiut Univ. 28:1999;33.
26. Aloisi G.G., Pignataro A.S. J. Chem. Soc., Faraday Trans. 1. 69:1973;934.
27. Mourad A.E. Spectrochim. Acta A. 39:1983;933.
28. Harvey A.E., Manning D.L. J. Am. Chem. Soc. 72:1950;4485.